Literature DB >> 12695351

Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes.

Hongbing Wang1, Stephanie R Faucette, Darryl Gilbert, Summer L Jolley, Tatsuya Sueyoshi, Masahiko Negishi, Edward L LeCluyse.   

Abstract

Although the glucocorticoid receptor (GR) facilitates the xenobiotic-induced expression of CYP2B in rodents, its role in the regulation of human CYP2B6 is unclear. In this report, the role of human GR in the regulation of CYP2B6 was evaluated using primary human hepatocytes and transfection assays with Huh7 cells. CYP2B6 expression was not induced in primary hepatocytes treated with dexamethasone (DEX) concentrations (0.01-1 microM) known to activate GR. In contrast, treatment with 0.1 microM DEX enhanced CYP2B6 induction by different pregnane X receptor (PXR) activators, including rifampin, phenytoin, clotrimazole, and phenobarbital. In Huh7 cells, cotransfection of human (h)GR and hPXR with CYP2B6-phenobarbital-responsive enhancer module (PBREM) reporter constructs revealed that all hPXR ligands induce CYP2B6 reporter gene activity, and this ligand-dependent activation is greatly enhanced by activated hGR. CYP2B6 reporter gene expression was not induced in the presence of hPXR ligands when hGR alone was cotransfected with CYP2B6 reporter construct. In hGR and human constitutive androstane receptor (hCAR) cotransfection assays, activated hGR increased the constitutive activation of PBREM reporter constructs by hCAR in the absence of inducers. In the presence of activated hGR and known inducers of CYP2B6, only PB treatment caused a further 2-fold activation of hCAR compared with control. These studies show that hGR is involved synergistically in the xenobiotic-responsive regulation of human CYP2B6 by hPXR and hCAR. Moreover, the results suggest that the GR-enhanced expression of CYP2B6 is mediated through an indirect mechanism that does not require increased expression of nuclear receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695351     DOI: 10.1124/dmd.31.5.620

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

Review 1.  Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s.

Authors:  Viola Tamási; Katalin Monostory; Russell A Prough; András Falus
Journal:  Cell Mol Life Sci       Date:  2010-12-24       Impact factor: 9.261

Review 2.  Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.

Authors:  Chaitali Ghosh; Vikram Puvenna; Jorge Gonzalez-Martinez; Damir Janigro; Nicola Marchi
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

3.  Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23.

Authors:  Deshi Shi; Dongfang Yang; Bingfang Yan
Journal:  Biochem Pharmacol       Date:  2010-07-01       Impact factor: 5.858

4.  Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.

Authors:  Zhihua Liu; Lei Li; Hong Wu; Jing Hu; Jun Ma; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2014-11-19       Impact factor: 3.922

5.  P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide.

Authors:  Keith A Hoffmaster; Ryan Z Turncliff; Edward L LeCluyse; Richard B Kim; Peter J Meier; Kim L R Brouwer
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

6.  Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.

Authors:  Stuart A Grossman; Jeffrey Olson; Tracy Batchelor; David Peereboom; Glenn Lesser; Serena Desideri; Xiaobu Ye; Tarek Hammour; Jeffrey G Supko
Journal:  Neuro Oncol       Date:  2008-02-20       Impact factor: 12.300

Review 7.  CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

Authors:  Hongbing Wang; Leslie M Tompkins
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

Review 8.  Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.

Authors:  Hongbing Wang; Edward L LeCluyse
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Regulation of hepatic bile acid transporters Ntcp and Bsep expression.

Authors:  Xingguo Cheng; David Buckley; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

10.  Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.

Authors:  Vishal S Narang; Charles Fraga; Narendra Kumar; Jun Shen; Stacy Throm; Clinton F Stewart; Christopher M Waters
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-04       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.